188 related articles for article (PubMed ID: 20615923)
1. Neuronal differentiation distinguishes supratentorial and infratentorial childhood ependymomas.
Andreiuolo F; Puget S; Peyre M; Dantas-Barbosa C; Boddaert N; Philippe C; Mauguen A; Grill J; Varlet P
Neuro Oncol; 2010 Nov; 12(11):1126-34. PubMed ID: 20615923
[TBL] [Abstract][Full Text] [Related]
2. Supra- and infratentorial pediatric ependymomas differ significantly in NeuN, p75 and GFAP expression.
Hagel C; Treszl A; Fehlert J; Harder J; von Haxthausen F; Kern M; von Bueren AO; Kordes U
J Neurooncol; 2013 Apr; 112(2):191-7. PubMed ID: 23371454
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of H3K27me3 in children with ependymoma.
Han Z; Kang P; Zhang H; Liao Z; Li C; Gong J; Liu W; Tian Y
Pediatr Blood Cancer; 2020 Mar; 67(3):e28121. PubMed ID: 31850684
[TBL] [Abstract][Full Text] [Related]
4. Both location and age predict survival in ependymoma: a SEER study.
McGuire CS; Sainani KL; Fisher PG
Pediatr Blood Cancer; 2009 Jan; 52(1):65-9. PubMed ID: 19006249
[TBL] [Abstract][Full Text] [Related]
5. Natural history and role of radiation in patients with supratentorial and infratentorial WHO grade II ependymomas: results from a population-based study.
Aizer AA; Ancukiewicz M; Nguyen PL; Macdonald SM; Yock TI; Tarbell NJ; Shih HA; Loeffler JS; Oh KS
J Neurooncol; 2013 Dec; 115(3):411-9. PubMed ID: 24057324
[TBL] [Abstract][Full Text] [Related]
6. Distinct disease-risk groups in pediatric supratentorial and posterior fossa ependymomas.
Godfraind C; Kaczmarska JM; Kocak M; Dalton J; Wright KD; Sanford RA; Boop FA; Gajjar A; Merchant TE; Ellison DW
Acta Neuropathol; 2012 Aug; 124(2):247-57. PubMed ID: 22526017
[TBL] [Abstract][Full Text] [Related]
7. The transcription factor evi-1 is overexpressed, promotes proliferation, and is prognostically unfavorable in infratentorial ependymomas.
Koos B; Bender S; Witt H; Mertsch S; Felsberg J; Beschorner R; Korshunov A; Riesmeier B; Pfister S; Paulus W; Hasselblatt M
Clin Cancer Res; 2011 Jun; 17(11):3631-7. PubMed ID: 21493867
[TBL] [Abstract][Full Text] [Related]
8. [Clinicopathologic analysis of ependymoma in childhood].
Zhou B; Li J; Luo Z
Zhonghua Bing Li Xue Za Zhi; 1995 Dec; 24(6):369-71. PubMed ID: 8732095
[TBL] [Abstract][Full Text] [Related]
9. Region Specific Differences of Claudin-5 Expression in Pediatric Intracranial Ependymomas: Potential Prognostic Role in Supratentorial Cases.
Virág J; Haberler C; Baksa G; Piurkó V; Hegedüs Z; Reiniger L; Bálint K; Chocholous M; Kiss A; Lotz G; Glasz T; Schaff Z; Garami M; Hegedűs B
Pathol Oncol Res; 2017 Apr; 23(2):245-252. PubMed ID: 27395057
[TBL] [Abstract][Full Text] [Related]
10. Altered MicroRNA Expression Is Associated with Tumor Grade, Molecular Background and Outcome in Childhood Infratentorial Ependymoma.
Zakrzewska M; Fendler W; Zakrzewski K; Sikorska B; Grajkowska W; Dembowska-Bagińska B; Filipek I; Stefańczyk Ł; Liberski PP
PLoS One; 2016; 11(7):e0158464. PubMed ID: 27390862
[TBL] [Abstract][Full Text] [Related]
11. Utility of copy number variants in the classification of intracranial ependymoma.
Evenson M; Cai C; Hucthagowder V; McNulty S; Neidich J; Kulkarni S; Dahiya S
Cancer Genet; 2020 Jan; 240():66-72. PubMed ID: 31794935
[TBL] [Abstract][Full Text] [Related]
12. Transcriptional profiling of paediatric ependymomas identifies prognostically significant groups.
Łastowska M; Matyja E; Sobocińska A; Wojtaś B; Niemira M; Szałkowska A; Krętowski A; Karkucińska-Więckowska A; Kaleta M; Ejmont M; Tarasińska M; Perek-Polnik M; Dembowska-Bagińska B; Pronicki M; Grajkowska W; Trubicka J
J Pathol Clin Res; 2021 Nov; 7(6):565-576. PubMed ID: 34314101
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical expression of cyclin D1 is higher in supratentorial ependymomas and predicts relapses in gross total resection cases.
de Andrade FG; Marie SK; Uno M; Matushita H; Taricco MA; Teixeira MJ; Rosemberg S; Oba-Shinjo SM
Neuropathology; 2015 Aug; 35(4):312-23. PubMed ID: 25946121
[TBL] [Abstract][Full Text] [Related]
14. Diagnostics of pediatric supratentorial RELA ependymomas: integration of information from histopathology, genetics, DNA methylation and imaging.
Pagès M; Pajtler KW; Puget S; Castel D; Boddaert N; Tauziède-Espariat A; Picot S; Debily MA; Kool M; Capper D; Sainte-Rose C; Chrétien F; Pfister SM; Pietsch T; Grill J; Varlet P; Andreiuolo F
Brain Pathol; 2019 May; 29(3):325-335. PubMed ID: 30325077
[TBL] [Abstract][Full Text] [Related]
15. Infant ependymoma in a 10-year AIEOP (Associazione Italiana Ematologia Oncologia Pediatrica) experience with omitted or deferred radiotherapy.
Massimino M; Gandola L; Barra S; Giangaspero F; Casali C; Potepan P; Di Rocco C; Nozza P; Collini P; Viscardi E; Bertin D; Biassoni V; Cama A; Milanaccio C; Modena P; Balter R; Tamburrini G; Peretta P; Mascarin M; Scarzello G; Fidani P; Milano GM; Sardi I; Genitori L; Garrè ML
Int J Radiat Oncol Biol Phys; 2011 Jul; 80(3):807-14. PubMed ID: 20646868
[TBL] [Abstract][Full Text] [Related]
16. A systematic review of treatment outcomes in pediatric patients with intracranial ependymomas.
Cage TA; Clark AJ; Aranda D; Gupta N; Sun PP; Parsa AT; Auguste KI
J Neurosurg Pediatr; 2013 Jun; 11(6):673-81. PubMed ID: 23540528
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical analysis of H3K27me3 demonstrates global reduction in group-A childhood posterior fossa ependymoma and is a powerful predictor of outcome.
Panwalkar P; Clark J; Ramaswamy V; Hawes D; Yang F; Dunham C; Yip S; Hukin J; Sun Y; Schipper MJ; Chavez L; Margol A; Pekmezci M; Chung C; Banda A; Bayliss JM; Curry SJ; Santi M; Rodriguez FJ; Snuderl M; Karajannis MA; Saratsis AM; Horbinski CM; Carret AS; Wilson B; Johnston D; Lafay-Cousin L; Zelcer S; Eisenstat D; Silva M; Scheinemann K; Jabado N; McNeely PD; Kool M; Pfister SM; Taylor MD; Hawkins C; Korshunov A; Judkins AR; Venneti S
Acta Neuropathol; 2017 Nov; 134(5):705-714. PubMed ID: 28733933
[TBL] [Abstract][Full Text] [Related]
18. Chromosome 1q gain and tenascin-C expression are candidate markers to define different risk groups in pediatric posterior fossa ependymoma.
Araki A; Chocholous M; Gojo J; Dorfer C; Czech T; Heinzl H; Dieckmann K; Ambros IM; Ambros PF; Slavc I; Haberler C
Acta Neuropathol Commun; 2016 Aug; 4(1):88. PubMed ID: 27550150
[TBL] [Abstract][Full Text] [Related]
19. Treatment and survival of supratentorial and posterior fossa ependymomas in adults.
Nuño M; Yu JJ; Varshneya K; Alexander J; Mukherjee D; Black KL; Patil CG
J Clin Neurosci; 2016 Jun; 28():24-30. PubMed ID: 26810473
[TBL] [Abstract][Full Text] [Related]
20. Surgical management of supratentorial ependymomas.
Chakraborty A; Harkness W; Phipps K
Childs Nerv Syst; 2009 Oct; 25(10):1215-20. PubMed ID: 19357853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
